Man Group’s Endocyte ECYT Stock Holding History
Bought
Maintained
Sold
Other funds holding ECYT
Man Group's ECYT Position: Q4 2018 in Review
Man Group sold out of Endocyte (ECYT) in Q4 2018, closing a stake of 162,813 shares — an estimated $2.89M sold.
Man Group first reported a position in ECYT in Q3 2018 and held it in 1 quarter. The position peaked at $2.89M in Q3 2018. 2 funds tracked by Wall St. Rank hold ECYT as of Q4 2018.
- Man Group reported no remaining Endocyte position as of Q4 2018 after selling out during the quarter.
- Man Group sold 162,813 Endocyte shares in Q4 2018, an estimated $2.89M.
- Man Group first reported a position in Endocyte in Q3 2018 and held it in 1 quarter.
- Man Group's Endocyte position peaked at $2.89M in Q3 2018.
- 2 funds tracked by Wall St. Rank held Endocyte as of Q4 2018.
Based on Man Group's 13F filing for Q4 2018, filed 14 Feb 2019.